Litigation Details for CELGENE CORPORATION v. APOTEX INC. (D.N.J. 2019)
✉ Email this page to a colleague
CELGENE CORPORATION v. APOTEX INC. (D.N.J. 2019)
Docket | ⤷ Try a Trial | Date Filed | 2019-02-13 |
Court | District Court, D. New Jersey | Date Terminated | 2020-10-28 |
Cause | 15:1126 Patent Infringement | Assigned To | Esther Salas |
Jury Demand | None | Referred To | Michael A. Hammer |
Parties | APOTEX INC. | ||
Patents | 6,315,720; 6,561,977; 6,755,784; 8,198,262; 8,315,886; 8,626,531; 8,673,939; 8,735,428; 8,828,427; 9,993,467 | ||
Attorneys | CHARLES MICHAEL LIZZA | ||
Firms | Saul Ewing Arnstein & Lehr LLP | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in CELGENE CORPORATION v. APOTEX INC.
Details for CELGENE CORPORATION v. APOTEX INC. (D.N.J. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-02-13 | 1 | States Patent Nos. 6,315,720 (“’720 patent”), 6,561,977 (“’977 patent”), 6,755,784 (“’784 patent”), 8,…(“’262 patent”), 8,315,886 (“’886 patent”), 8,626,531(“’531 patent”), 8,673,939 (“’939 patent”), 8,735,428…United States Patent Nos. 10,093,647 (the “’647 patent”), 10,093,648 (the “’648 patent”), and 10,093,649…8,735,428 (“’428 patent”), 8,828,427 (“’427 patent”), and 9,993,467 (“’467 patent”) are invalid, unenforceable… 1. This is an action for patent infringement under the patent laws of the United States, 35 | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |